Search results for "Highlights"
EoE patients with high BMI may be less likely to respond to topical corticosteroids
A retrospective cohort study of patients with eosinophilic esophagitis (EoE) found that each 1-point increase in body mass index (BMI) was associated with a 7% decrease in odds of histologic response to topical corticosteroids and that patients with obesity had about 40% odds of responding compared to those without.
https://gastroenterology.acponline.org/archives/2022/12/23/2.htm
23 Dec 2022
IV iron regimens compared for serum phosphate effects in patients with IBD
Ferric carboxymaltose and ferric derisomaltose worked well to resolve anemia from inflammatory bowel disease (IBD), but the former was associated with low serum phosphate levels, according to an industry-funded trial.
https://gastroenterology.acponline.org/archives/2022/09/23/2.htm
23 Sep 2022
Societies issue joint statement on metabolic, bariatric surgery
The American Society for Metabolic and Bariatric Surgery and the International Federation for the Surgery of Obesity and Metabolic Disorders support surgery for patients with a body mass index of 35 kg/m2 or higher regardless of comorbid conditions, among other guidance.
https://gastroenterology.acponline.org/archives/2022/11/18/3.htm
18 Nov 2022
DPP-4 inhibitors associated with risk of cholecystitis, meta-analysis finds
Patients with type 2 diabetes who were randomized to receive dipeptidyl peptidase-4 (DPP-4) inhibitors had higher rates of gallbladder disease than those who got placebo or nonincretin drugs, but no difference in risk of cholelithiasis or biliary diseases.
https://gastroenterology.acponline.org/archives/2022/07/22/6.htm
22 Jul 2022
Electronic alert about lactulose linked to lower readmissions in patients with cirrhosis
The alert, which encouraged clinicians to prescribe rifaximin for patients with cirrhosis and hepatic encephalopathy who were on lactulose, increased uptake of rifaximin in such patients.
https://gastroenterology.acponline.org/archives/2022/01/28/3.htm
28 Jan 2022
New guideline offers recommendations on managing antithrombotic drugs during GI bleeds, endoscopies
The American College of Gastroenterology and the Canadian Association of Gastroenterology offered suggestions for management of patients on warfarin, direct oral anticoagulants, and antiplatelet agents.
https://gastroenterology.acponline.org/archives/2022/03/25/1.htm
25 Mar 2022
Poor oral health associated with hospitalizations in outpatients with cirrhosis
Over three months, patients with cirrhosis who were hospitalized for nonelective reasons were more likely than those who were not to be decompensated, with higher rates of minimal hepatic encephalopathy plus frailty and history of periodontitis.
https://gastroenterology.acponline.org/archives/2022/11/18/2.htm
18 Nov 2022
Heart failure risk increased in patients with NAFLD, meta-analysis finds
Nonalcoholic fatty liver disease (NAFLD) was associated with a 50% increased risk of new-onset heart failure, independent of age, sex, diabetes, hypertension, and other common cardiovascular risk factors, according to an international meta-analysis.
https://gastroenterology.acponline.org/archives/2022/08/26/2.htm
26 Aug 2022
HCV medications decreased liver disease among those using injection drugs
A Baltimore-based study found that half of participants with chronic hepatitis C virus (HCV) and a history of injection drug use at baseline were free of the virus by 2019, with associated reductions in their risk of cirrhosis and mortality.
https://gastroenterology.acponline.org/archives/2022/07/22/2.htm
22 Jul 2022
Excess weight over time associated with increased CRC risk
A German study found that the weighted number of years lived with overweight and obesity was associated with a higher risk for colorectal cancer (CRC) than excess body mass index at a single point in time.
https://gastroenterology.acponline.org/archives/2022/03/25/3.htm
25 Mar 2022